Introduction

Buparvaquone, a synthetic antiprotozoal compound, has garnered significant attention in the pharmaceutical and chemical industries for its potential in treating parasitic infections. With a molecular formula of C₂₁H₂₆O₃ and a molecular weight of 326.43 g/mol, this compound is characterized by its yellow powder appearance and complex structural framework. This article provides an in-depth analysis of Buparvaquone, covering its technical specifications, applications, and the company behind its development—Hebei Guangxing Chemical Co., Ltd..

Product Overview

Buparvaquone, also known by its synonyms such as BW-720C, CS-1178, and Butalex, is a derivative of naphthoquinone. Its chemical structure features a 2-((4-tert-butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthoquinone backbone, which contributes to its pharmacological activity. The compound is typically available as a yellow powder, making it easy to handle and incorporate into various formulations.

The structural formula of Buparvaquone is depicted in the image below, showcasing its unique molecular arrangement:

Technical Specifications

These specifications highlight Buparvaquone’s chemical properties, which are critical for its application in pharmaceutical research and development. The compound’s stability and solubility characteristics make it a valuable component in the formulation of antiprotozoal drugs.

Applications and Uses

Buparvaquone is primarily used as an antiprotozoal agent, targeting various parasitic infections. Its mechanism of action involves inhibiting the growth of protozoa by disrupting their metabolic pathways. This makes it particularly effective against parasites such as Trypanosoma and Leishmania, which are responsible for diseases like African sleeping sickness and leishmaniasis.

According to the National Institute of Standards and Technology (NIST), the development of compounds like Buparvaquone is essential for advancing medical research and ensuring the accuracy of chemical measurements in pharmaceutical applications. NIST’s role in standardizing chemical properties and analytical methods underscores the importance of rigorous testing and validation in drug development.

In addition to its pharmaceutical applications, Buparvaquone is utilized in the chemical industry for the synthesis of other compounds. Its structural versatility allows it to be modified for various purposes, including the creation of new drugs and the development of chemical intermediates.

Company Background: Hebei Guangxing Chemical Co., Ltd.

Hebei Guangxing Chemical Co., Ltd. is a leading manufacturer and supplier of specialty chemicals, including Buparvaquone. With a commitment to quality and innovation, the company has established itself as a trusted partner in the chemical industry. Located in Hebei, China, the company leverages advanced manufacturing technologies and strict quality control measures to produce high-purity chemical products.

Hebei Guangxing Chemical Co., Ltd. specializes in the production of pharmaceutical intermediates, fine chemicals, and research chemicals. Their product portfolio includes a wide range of compounds, each designed to meet the specific needs of their clients. The company’s dedication to research and development ensures that they remain at the forefront of chemical innovation.

For more information about the company and its products, visit Hebei Guangxing Chemical Co., Ltd..

Advantages of Buparvaquone

Buparvaquone offers several advantages that make it a preferred choice in the pharmaceutical industry:

• High Potency: Buparvaquone exhibits strong antiprotozoal activity, making it effective against a broad spectrum of parasites.
• Structural Stability: The compound’s molecular structure ensures stability under various conditions, facilitating its use in different formulations.
• Cost-Effectiveness: As a synthetic compound, Buparvaquone can be produced at a lower cost compared to naturally derived alternatives.
• Research Applications: Its unique properties make it a valuable tool for researchers studying parasitic diseases and developing new treatments.

These advantages highlight the compound’s versatility and potential for future applications in both medical and industrial settings.

Challenges and Considerations

While Buparvaquone presents numerous benefits, there are also challenges associated with its use. One of the primary concerns is the potential for drug resistance, which can develop due to the overuse or misuse of antiprotozoal agents. To mitigate this risk, it is essential to follow prescribed dosages and treatment protocols.

Additionally, the compound’s solubility in water and other solvents may require formulation adjustments to enhance its bioavailability. Researchers and manufacturers must also consider the environmental impact of Buparvaquone and ensure that its production and disposal processes adhere to regulatory standards.

Conclusion

Buparvaquone represents a significant advancement in the field of antiprotozoal compounds, offering a potent and versatile solution for combating parasitic infections. Its unique chemical structure, coupled with the expertise of Hebei Guangxing Chemical Co., Ltd., ensures that this compound meets the highest standards of quality and efficacy. As research continues to uncover new applications for Buparvaquone, its role in the pharmaceutical industry is likely to expand, contributing to the development of innovative treatments for parasitic diseases.

References

1. National Institute of Standards and Technology (NIST). (n.d.). Standards and Measurements. Retrieved from https://www.nist.gov.

2. Hebei Guangxing Chemical Co., Ltd.. (n.d.). Buparvaquone Product Page. Retrieved from https://www.hbgxchemical.com/buparvaquone-115.html.